Lataa...
Pulmonary vasodilators: beyond the bounds of pulmonary arterial hypertension therapy in COVID-19
Pulmonary arterial hypertension (PAH) and novel coronavirus (SARS-CoV-2) disease COVID-19 are characterized by extensive endothelial dysfunction and inflammation leading to vascular remodeling and severe microthrombi and microvascular obliterative disease. It is hypothesized that those patients with...
Tallennettuna:
| Julkaisussa: | Pulm Circ |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7686637/ https://ncbi.nlm.nih.gov/pubmed/33282201 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045894020970369 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|